Latest Health News
International Day of Epidemic Preparedness Observed Globally
Today, December 27, 2025, marks the International Day of Epidemic Preparedness, emphasizing resilient communities and UN coordination to prevent epidemics. The UN highlights governments' roles and women's contributions in health workforce, urging inclusive participation for vulnerable groups.
WHO supports national efforts toward the 2030 Agenda for infectious disease mitigation.
Ongoing Myiasis Outbreak in Mexico
ProMED reports a myiasis case in Mexico on December 27, 2025, part of continued monitoring of global health threats. Myiasis involves fly larvae infesting human tissue, posing risks in affected regions.
This alerts health authorities to preventive measures.
Lassa Fever Update in Nigeria with Fatalities
Nigeria sees ongoing Lassa fever with 44 cases and fatalities reported on December 24, 2025, amid high mortality rates. Earlier updates noted 43 cases with high fatalities on December 20.
Public health responses urge vigilance and containment.
Salmonellosis from Raw Oysters in USA
CDC reports salmonellosis linked to serotype Telavivekbir from raw oysters in the USA on December 24, 2025. Consumers are advised to avoid raw oysters to prevent infections.
This outbreak underscores food safety risks.
Avian Influenza H5N1 in Taiwan Poultry
High-path avian influenza H5N1 confirmed in poultry in Taipei, Taiwan, on December 22, 2025, per WOAH reports. This raises concerns for zoonotic transmission and poultry industry impacts.
Surveillance and culling measures are implemented.
Huntington's Disease Slowed by Experimental RNA Drug
A virus-delivered RNA therapy slowed Huntington's progression by up to 75% in trials, marking a first for the neurodegenerative disorder. Injected into the brain, it halts disease-causing proteins.
This offers hope for patients with no prior effective treatments.
First Personalized CRISPR Gene Therapy Saves Baby from Ammonia Buildup
Baby KJ received custom CRISPR therapy erasing a mutation causing deadly ammonia levels, the first such personalized treatment. A new trial plans broader application for rare diseases.
This breakthrough demonstrates gene editing's life-saving potential.
Successful First Bladder Transplant Performed
Urologic surgeons completed the first bladder transplant, overcoming complex vessel and nerve reattachments. The patient's urine drainage functions well, with ongoing monitoring.
This advances organ transplant capabilities.
Ropeginterferon Alfa-2b Superior for Essential Thrombocythemia
Phase 3 SURPASS-ET trial showed ropeginterferon alfa-2b outperforming anagrelide, with 42.9% durable response vs 6%. It reduces JAK2 V617F allele burden in blood cancer patients.
This shifts treatment standards for ET.
BTK Degraders Emerge for Resistant CLL
Bruton tyrosine kinase degraders show high response rates in chronic lymphocytic leukemia resistant to standard BTK inhibitors. They address acquired mutations with manageable safety.
Early data promise new options for relapsed patients.
Alzheimer's Advances: Blood Tests and Leqembi Home Injections Approved
FDA cleared two blood tests for Alzheimer's brain changes and approved weekly at-home Leqembi injections after initial infusions. These ease diagnosis, reduce burdens, and improve access.
ALZPro portal aids clinicians in care.
COVID Vaccines Enhance Cancer Immunotherapy Outcomes
mRNA COVID vaccines improved survival in lung and skin cancer patients on immunotherapy, possibly by immune activation. Vaccinated patients lived longer than unvaccinated counterparts.
Researchers explore mRNA's anticancer potential.